AlanJKatzMD

PubMed

• 1 citations
  Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.
  Jesus E. Juarez, Tahmineh Romero, Constantine Mantz, Abigail Pepin, Nima Aghdam, Simeng Suy, Michael L. Steinberg, Rebecca Levin-Epstein, Nicholas G. Nickols, Irving D...> ;Advances in Radiation Oncology. 2021 Aug 28
• 22 citations
  Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
  Ritchell van Dams, Naomi Y. Jiang, Donald B. Fuller, Andrew Loblaw, Tommy Jiang, Alan J. Katz, Sean P. Collins, Nima Aghdam, Simeng Suy, Kevin L. Stephans, Ye Yuan, Ni...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Jan 23
• 201 citations
  Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
  Amar U. Kishan, Audrey Dang, Alan J. Katz, Constantine Mantz, Sean P. Collins, Nima Aghdam, Fang-I Chu, Irving D. Kaplan, Limor Appelbaum, Donald B. Fuller, Robert M. ...> ;JAMA Network Open. 2019 Feb 1
• Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.
  Jiang, P., Jiang, P., Krockenberger, K., Krockenberger, K., Vonthein, R., Vonthein, R., Tereszczuk, J., Tereszczuk, J., Schreiber, A., Schreiber, A., Liebau, S., Lieba...> ;Radiation oncology (London, England). 2017 Aug 20
• 83 citations
  Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study
  Alan J. Katz, Josephine Kang> ;Frontiers in Oncology. 2014 Oct 28
• 68 citations
  Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study
  Alan J. Katz, Josephine Kang> ;Frontiers in Oncology. 2014 Sep 2
• 173 citations
  Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study.
  Alan J. Katz, Josephine Kang> ;Radiation Oncology. 2014 Jan 1
• 150 citations
  Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.
  Alan J. Katz, Michael Santoro, Fred Diblasio, Richard A. Ashley> ;Radiation Oncology. 2013 May 13
• 20 citations
  Cyberknife radiosurgery in treating trigeminal neuralgia
  Bryan M. Lazzara, Orlando Ortiz, Ritu Bordia, Matthew Witten, Jonathan A. Haas, Alan J. Katz, Jeffrey A Brown> ;Journal of Neurointerventional Surgery. 2013 Jan 1
• 17 citations
  Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
  Alan J. Katz, Montserrat Ferrer, José Francisco Suárez> ;Radiation Oncology. 2012 Nov 20
• 15 citations
  Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
  Alan J. Katz, Michael Santoro, Richard Ashley, Ferdinand Diblasio> ;Frontiers in Oncology. 2011 Dec 5
• 48 citations
  Stereotactic body radiotherapy as boost for organ-confined prostate cancer.
  Alan J. Katz, Michael Santoro, Richard Ashley, Ferdinand Diblasio, Matthew Witten> ;Technology in Cancer Research & Treatment. 2010 Dec 1
• 20 citations
  CyberKnife radiosurgery for prostate cancer.
  Alan J. Katz> ;Technology in Cancer Research & Treatment. 2010 Oct 1
• 115 citations
  Stereotactic body radiotherapy for organ-confined prostate cancer
  Alan J. Katz, Michael Santoro, Richard Ashley, Ferdinand Diblasio, Matthew Witten> ;BMC Urology. 2010 Feb 1
• 15 citations
  Genetic and cellular mechanisms in chromium and nickel carcinogenesis considering epidemiologic findings.
  Arthur Chiu, Alan J. Katz, Jefferson Beaubier, Nancy Chiu, Xianglin Shi> ;Molecular and Cellular Biochemistry. 2004 Jan 1
• 9 citations
  Combining Drosophila melanogaster somatic-mutation-recombination and electron-spin-resonance-spectroscopy data to interpret epidemiologic observations on chromium carc...
  Alan J. Katz, Arthur Chiu, Jefferson Beaubier, Xianglin Shi> ;Molecular and Cellular Biochemistry. 2001 Jun 1
• 7 citations
  Relationships between structures and mutagenic potencies of 16 heterocyclic nitrogen mustards (ICR compounds) in Salmonella typhimurium
  David M. DeMarini, Hoang N. Pham, Alan J. Katz, Herman E. Brockman> ;Mutation Research. 1984 Jun 1
• Join now to see all